CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- CT ORDER Other Confidential Order
- CT ORDER Other Confidential Order
- 4 Open-market buy Director bought 10,000 shares at an average $23.49 ($234,910)
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market sale EVP AND GC sold 36,558 shares at $32.39 ($1,184,055)
- 4 Option exercise EVP AND GC acquired 50,179 shares (option exercise)
- 4 Open-market sale EVP AND GC sold 74,321 shares at $30.14 ($2,240,139)
- 4 Open-market sale Director sold 25,000 shares at $30.06 ($751,543)
- 4 Shares withheld for taxes Director gave up 1,941 shares (to pay taxes)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13D/A Stake Beneficial Ownership Report
- 4 Option exercise Director acquired 1,426,590 shares (option exercise)
- 4 Open-market sale EVP AND GC sold 37,500 shares at $40.91 ($1,534,043)
- CT ORDER Other Confidential Order
Page 28 of 70 · 1,382 filings